Dashboard
Manage Tickers

MRNA Moderna, Inc.

Nasdaq modernatx.com


$ 23.69 $ 1.36 (6.08 %)    

Friday, 21-Nov-2025 15:56:32 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 589.60 $ 4.40 (0.75 %)
DIA $ 462.45 $ 5.05 (1.1 %)
SPY $ 658.47 $ 6.50 (1 %)
TLT $ 89.50 $ 0.27 (0.3 %)
GLD $ 373.70 $ -0.58 (-0.15 %)
$ 23.72
$ 22.39
$ 23.65 x 315
$ 23.60 x 215
$ 22.30 - $ 23.94
$ 22.28 - $ 48.92
13,904,547
na
9.27B
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-21-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-03-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

first-ever-human-h5n5-case-turns-fatal-in-washington-state
First-Ever Human H5N5 Case Turns Fatal In ...
11/22/2025 18:07:45

Washington reports world's first fatal human H5N5 bird flu case; officials say risk to public remains low, monitoring conti...

piper-sandler-reiterates-overweight-on-moderna-lowers-price-target-to-63
Piper Sandler Reiterates Overweight on Mod...
11/21/2025 17:18:28

Piper Sandler analyst Edward Tenthoff reiterates Moderna (NASDAQ:MRNA) with a Overweight and lowers the price target from $6...

rbc-capital-maintains-sector-perform-on-moderna-lowers-price-target-to-25
RBC Capital Maintains Sector Perform on Mo...
11/21/2025 14:45:34

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and lowers the price target from $28 to ...

leerink-partners-maintains-underperform-on-moderna-raises-price-target-to-18
Leerink Partners Maintains Underperform on...
11/21/2025 14:37:35

Leerink Partners analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from ...

walmart-intuit-the-gap-sandisk-and-moderna-why-these-5-stocks-are-on-investors-radars-today
Walmart, Intuit, The Gap, SanDisk And Mode...
11/21/2025 01:30:45

WMT, INTU, GAP, SNDK, MRNA were the stocks seen trending on Thursday, Nov. 20, 2025.

whats-going-on-with-moderna-stock
What's Going On With Moderna Stock?
11/20/2025 17:41:35

Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business stra...

moderna-improves-2026-and-2027-expected-gaap-operating-expenses-by-05b-each-year-on-path-to-targeted-cash-breakeven-in-2028
Moderna Improves 2026 And 2027 Expected GA...
11/20/2025 12:11:47

moderna-expects-to-expand-seasonal-vaccine-franchise-from-three-to-up-to-six-approved-products-by-2028
Moderna Expects To Expand Seasonal Vaccine...
11/20/2025 12:09:32

moderna-announces-3-yr-business-strategy-and-commercial-growth-drivers-targeting-up-to-10-revenue-growth-in-2026
Moderna Announces 3-Yr Business Strategy A...
11/20/2025 12:08:50

moderna-closes-5-yr-term-loan-facility-for-up-to-15b-of-capital-from-ares-management-credit-funds
Moderna Closes 5-Yr Term Loan Facility For...
11/20/2025 12:07:06

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2...

moderna-expands-us-manufacturing-capabilities-with-onshoring-of-drug-product-manufacturing-to-existing-moderna-technology-center-in-norwood-massachusetts
Moderna Expands U.S. Manufacturing Capabil...
11/19/2025 12:08:30

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing networkMore than $...

merck-makes-big-bet-on-flu-protection-with-cidara-buyout
Merck Makes Big Bet On Flu Protection With...
11/14/2025 14:32:24

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

b-of-a-securities-maintains-underperform-on-moderna-lowers-price-target-to-21
B of A Securities Maintains Underperform o...
11/10/2025 12:11:57

B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and lowers the price target from ...

barclays-maintains-equal-weight-on-moderna-lowers-price-target-to-25
Barclays Maintains Equal-Weight on Moderna...
11/07/2025 15:39:51

Barclays analyst Gena Wang maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and lowers the price target from $31 to $25.

ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday
AI Stocks Slide Again, Bitcoin Dips Near $...
11/06/2025 17:45:11

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

mrna-vaccine-maker-moderna-lowers-rd-spending-tightens-sales-forecast
mRNA Vaccine Maker Moderna Lowers R&D Spen...
11/06/2025 17:29:25

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand...

moderna-q3-2025-earnings-call-transcript
Moderna Q3 2025 Earnings Call Transcript
11/06/2025 17:08:17

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been prov...

moderna-narrows-fy2025-sales-guidance-from-1500b-2200b-to-1600b-2000b-vs-1899b-est
Moderna Narrows FY2025 Sales Guidance from...
11/06/2025 12:02:42

Moderna (NASDAQ:MRNA) narrows FY2025 sales outlook from $1.500 billion-$2.200 billion to $1.600 billion-$2.000 billion vs $1.89...

moderna-q3-eps-051-beats-202-estimate-sales-1016b-beat-886539m-estimate
Moderna Q3 EPS $(0.51) Beats $(2.02) Estim...
11/06/2025 12:02:07

Moderna (NASDAQ:MRNA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(2.02) by 74...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION